» Articles » PMID: 36340038

Participation of OCRL1, and APPL1, in the Expression, Proteolysis, Phosphorylation and Endosomal Trafficking of Megalin: Implications for Lowe Syndrome

Overview
Specialty Cell Biology
Date 2022 Nov 7
PMID 36340038
Authors
Affiliations
Soon will be listed here.
Abstract

Megalin/LRP2 is the primary multiligand receptor for the re-absorption of low molecular weight proteins in the proximal renal tubule. Its function is significantly dependent on its endosomal trafficking. Megalin recycling from endosomal compartments is altered in an X-linked disease called Lowe Syndrome (LS), caused by mutations in the gene encoding for the phosphatidylinositol 5-phosphatase OCRL1. LS patients show increased low-molecular-weight proteins with reduced levels of megalin ectodomain in the urine and accumulation of the receptor in endosomal compartments of the proximal tubule cells. To gain insight into the deregulation of megalin in the LS condition, we silenced OCRL1 in different cell lines to evaluate megalin expression finding that it is post-transcriptionally regulated. As an indication of megalin proteolysis, we detect the ectodomain of the receptor in the culture media. Remarkably, in OCRL1 silenced cells, megalin ectodomain secretion appeared significantly reduced, according to the observation in the urine of LS patients. Besides, the silencing of APPL1, a Rab5 effector associated with OCRL1 in endocytic vesicles, also reduced the presence of megalin's ectodomain in the culture media. In both silencing conditions, megalin cell surface levels were significantly decreased. Considering that GSK3ß-mediated megalin phosphorylation reduces receptor recycling, we determined that the endosomal distribution of megalin depends on its phosphorylation status and OCRL1 function. As a physiologic regulator of GSK3ß, we focused on insulin signaling that reduces kinase activity. Accordingly, megalin phosphorylation was significantly reduced by insulin in wild-type cells. Moreover, even though in cells with low activity of OCRL1 the insulin response was reduced, the phosphorylation of megalin was significantly decreased and the receptor at the cell surface increased, suggesting a protective role of insulin in a LS cellular model.

Citing Articles

Vacuolar H-ATPase and Megalin-Mediated Prorenin Uptake: Focus on Elements Beyond the (Pro)Renin Receptor.

Wang N, Lu X, Danser A J Cell Physiol. 2025; 240(1):e31518.

PMID: 39745029 PMC: 11694337. DOI: 10.1002/jcp.31518.


Megalin: A Sidekick or Nemesis of the Kidney?.

Kulkarni K, Hussain T J Am Soc Nephrol. 2024; 36(2):293-300.

PMID: 39607686 PMC: 11801750. DOI: 10.1681/ASN.0000000572.


OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses.

Fuentealba L, Pizarro H, Marzolo M Biomolecules. 2024; 14(7).

PMID: 39062513 PMC: 11274606. DOI: 10.3390/biom14070799.

References
1.
Sotelo P, Farfan P, Benitez M, Bu G, Marzolo M . Sorting nexin 17 regulates ApoER2 recycling and reelin signaling. PLoS One. 2014; 9(4):e93672. PMC: 3976305. DOI: 10.1371/journal.pone.0093672. View

2.
Perez Bay A, Schreiner R, Benedicto I, Paz Marzolo M, Banfelder J, Weinstein A . The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells. Nat Commun. 2016; 7:11550. PMC: 4873671. DOI: 10.1038/ncomms11550. View

3.
Sroka I, McDaniel K, Nagle R, Bowden G . Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression. Prostate. 2008; 68(5):463-76. DOI: 10.1002/pros.20718. View

4.
Toi N, Inaba M, Ishimura E, Tsugawa N, Imanishi Y, Emoto M . Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients. Sci Rep. 2019; 9(1):2207. PMC: 6379559. DOI: 10.1038/s41598-019-38613-8. View

5.
Wang X, Ma D, Keski-Oja J, Pei D . Co-recycling of MT1-MMP and MT3-MMP through the trans-Golgi network. Identification of DKV582 as a recycling signal. J Biol Chem. 2003; 279(10):9331-6. DOI: 10.1074/jbc.M312369200. View